- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05980637
Effectiveness and Safety of Shaoyao Gancao Decoction With Addition on the Sleep-related Leg Cramps
Effectiveness and Safety of Shaoyao Gancao Decoction With Addition on the Sleep-related Leg Cramps: A Randomized, Double-Blinded, Placebo-Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The sleep-related leg cramps (SRLC), also called nocturnal leg cramps (NLC), is a sleep-related limb movement disorder in which painful contractions of the calf or foot muscles occur during sleep, thereby interrupting the patient's rest. It can happen at any ages, but is particularly prevalent among the elderly.
In Chinese medicine, leg cramps, first mentioned in the book of "Huangdi Neijing" (The Yellow Emperor's Cannon of Internal Classic), is characterized by muscular spasm and contracture of a limb resulting in difficulty in relaxation and movement. SRLC is an impediment disease caused by the invasion of wind-cold damp pathogens in the muscles and sinews, together with the dual deficiency of qi and blood that fails to nourish the muscles and sinews, leading to painful contraction of muscles.
Currently, no treatments have been proven both safe and effective for SRLC. Passive stretching and deep tissue massage, which are patient-controlled maneuvers on relieving muscle tension, are usually recommended despite limited proof of effectiveness.
Shaoyao Gancao Decoction was first introduced in the book of "Shang Han Lun" (Treatise on Cold Attack) written by the venerated Physician Zhang Zhongjing in the Eastern Han dynasty. It consists of two herbs, i.e., Paeoniae Radix Alba and Glycyrrhizae Radix et Rhizoma Praeparata Cum Melle, and has the therapeutic functions of moderating painful spasms and alleviating pain. It is commonly used in Chinese medicine practice for treating abdominal pain, lack of strength in walking, spasms of the calf muscles, and restless leg syndrome. Modern pharmacological studies showed that Shaoyao Gancao Decoction possesses anti-inflammatory, analgesic and antispasmodic effects. It has been shown that the use of Shaoyao Gancao Decoction could inhibit mechanical and thermal hyperalgesia in rats with chronic compressive injury.
In 2009, a prospective observational pilot study was conducted to evaluate the effectiveness and safety of modified Shaoyao Gancao Decoction on 30 eligible subjects with SRLC in a cohort study and the result is positive.
Based on the positive results of the pilot study, it shows that SGDA is a promising herbal treatment method for SRLC, and propose a randomized, double-blinded and placebo-controlled trial to scientifically determine the effectiveness and safety of this formula for the treatment of Shaoyao Gancao Decoction with Addition (SGDA) of SRLC. Subjects will be randomized into a treatment group or placebo group for 4 weeks, and then post-treatment visits at week 6 and week 8.
Study Type
Enrollment (Estimated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
- Name: Zhixiu Lin, PhD
- Phone Number: 35053476
- Email: linzx@cuhk.edu.hk
Study Contact Backup
- Name: Tin Muk Ho, Master
- Phone Number: 39433505
- Email: raytmho@cuhk.edu.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Hong Kong Institute of Integrative Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 60 or above of both genders;
- Complain of muscular spasm and contracture of the lower limb with difficulty in relaxation and movement at night;
- Meet the diagnostic criteria of The International Classification of Sleep Disorders (3rd Edition) for SRLC [2];
- Meet the syndrome differentiation of the blood stasis or blood deficiency in Traditional Chinese Medicine.
- Regular SRLC occurs at least once per week on average within past month;
- Numeric Pain Rating Scale (NPRS) ≥ 5; and
- Willing to provide written informed consent.
Exclusion Criteria:
- Known mental disorder or neurologic disorder;
- Known serious organic disease including severe cardiovascular disease, post-stroke depression, cancer and dementia,;
- Currently on anticoagulants, antiplatelet medications, hypnotics, anxiolytics, positive inotropic drugs, corticosteroids and estrogenic and testosterone which may interfere with the study medications.
- Impaired hematological profile and liver / renal function exceeds the upper limit of the reference value by 2 times;
- Known allergic to Chinese medicines; and
- Any contraindications for taking Chinese medicines in the opinion of the investigators;
- Known history of lower limb surgery;
- Known pregnant or breast-feeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Shaoyao Gancao Decoction with Addition
11g of Shaoyao Gancao Decoction with Addition granules twice daily for 4 weeks
|
11g twice daily for 4 weeks
Other Names:
|
Placebo Comparator: Placebo
11g of placebo granules twice daily for 4 weeks
|
11g twice daily for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change in the Visual Analogue Scale (VAS) of painfulness
Time Frame: week 4
|
The VAS is a unidimensional measure of pain intensity which will be self assessed by subjects daily, with the scale of 0 (no pain) to 10 (worst imaginable pain).
|
week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change in the Visual Analogue Scale (VAS) of painfulness
Time Frame: week 2
|
The VAS is a unidimensional measure of pain intensity which will be self assessed by subjects daily, with the scale of 0 (no pain) to 10 (worst imaginable pain).
|
week 2
|
The change in the Visual Analogue Scale (VAS) of painfulness
Time Frame: week 6
|
The VAS is a unidimensional measure of pain intensity which will be self assessed by subjects daily, with the scale of 0 (no pain) to 10 (worst imaginable pain).
|
week 6
|
The change in the Visual Analogue Scale (VAS) of painfulness
Time Frame: week 8
|
The VAS is a unidimensional measure of pain intensity which will be self assessed by subjects daily, with the scale of 0 (no pain) to 10 (worst imaginable pain).
|
week 8
|
The change in frequency of SRLC
Time Frame: week 2
|
Frequency of SRLC will be recorded by subjects daily.
|
week 2
|
The change in frequency of SRLC
Time Frame: week 4
|
Frequency of SRLC will be recorded by subjects daily.
|
week 4
|
The change in frequency of SRLC
Time Frame: week 6
|
Frequency of SRLC will be recorded by subjects daily.
|
week 6
|
The change in frequency of SRLC
Time Frame: week 8
|
Frequency of SRLC will be recorded by subjects daily.
|
week 8
|
The change in total duration of SRLC per week
Time Frame: week 2
|
Duration of SRLC will be recorded by subjects daily.
|
week 2
|
The change in total duration of SRLC per week
Time Frame: week 4
|
Duration of SRLC will be recorded by subjects daily.
|
week 4
|
The change in total duration of SRLC per week
Time Frame: week 6
|
Duration of SRLC will be recorded by subjects daily.
|
week 6
|
The change in total duration of SRLC per week
Time Frame: week 8
|
Duration of SRLC will be recorded by subjects daily.
|
week 8
|
The change in the Short Form 36 Health Survey Questionnaire (SF-36) score
Time Frame: week 2
|
The SF-36 is a 36-item scale, which measures eight domains of health status: physical functioning; physical role limitations; bodily pain; general health perceptions; energy/vitality; social functioning; emotional role limitations and mental health. It will be self assessed by subjects. The scores are transformed to range from 0 (where the respondent has the worst possible health) to 100 (where the respondent is in the best possible health). |
week 2
|
The change in the Short Form 36 Health Survey Questionnaire (SF-36) score
Time Frame: week 4
|
The SF-36 is a 36-item scale, which measures eight domains of health status: physical functioning; physical role limitations; bodily pain; general health perceptions; energy/vitality; social functioning; emotional role limitations and mental health. It will be self assessed by subjects. The scores are transformed to range from 0 (where the respondent has the worst possible health) to 100 (where the respondent is in the best possible health). |
week 4
|
The change in the Short Form 36 Health Survey Questionnaire (SF-36) score
Time Frame: week 6
|
The SF-36 is a 36-item scale, which measures eight domains of health status: physical functioning; physical role limitations; bodily pain; general health perceptions; energy/vitality; social functioning; emotional role limitations and mental health. It will be self assessed by subjects. The scores are transformed to range from 0 (where the respondent has the worst possible health) to 100 (where the respondent is in the best possible health). |
week 6
|
The change in the Short Form 36 Health Survey Questionnaire (SF-36) score
Time Frame: week 8
|
The SF-36 is a 36-item scale, which measures eight domains of health status: physical functioning; physical role limitations; bodily pain; general health perceptions; energy/vitality; social functioning; emotional role limitations and mental health. It will be self assessed by subjects. The scores are transformed to range from 0 (where the respondent has the worst possible health) to 100 (where the respondent is in the best possible health). |
week 8
|
The change in the Pittsburg Sleep Quality Index (PSQI)
Time Frame: week 2
|
PSQI measures the quality and pattern of sleep in older adult by measuring seven domains in 19 questions, which will be self-assessed by subjects.The scoring is 0-3 on a Likert scale.
|
week 2
|
The change in the Pittsburg Sleep Quality Index (PSQI)
Time Frame: week 4
|
PSQI measures the quality and pattern of sleep in older adult by measuring seven domains in 19 questions, which will be self-assessed by subjects.The scoring is 0-3 on a Likert scale.
|
week 4
|
The change in the Pittsburg Sleep Quality Index (PSQI)
Time Frame: week 6
|
PSQI measures the quality and pattern of sleep in older adult by measuring seven domains in 19 questions, which will be self-assessed by subjects.The scoring is 0-3 on a Likert scale.
|
week 6
|
The change in the Pittsburg Sleep Quality Index (PSQI)
Time Frame: week 8
|
PSQI measures the quality and pattern of sleep in older adult by measuring seven domains in 19 questions, which will be self-assessed by subjects.The scoring is 0-3 on a Likert scale.
|
week 8
|
The score of Patient Global Impression of Change (PGIC)
Time Frame: week 2
|
PGIC is a self-reported measure which reflects a patient's impression on the efficacy of treatment.
It is a 7-point scale detecting patient's rating on the overall improvement of treatment.
The patient can rate from 1 (very much improved) to 4 (no change) to 7 (very much worse).
|
week 2
|
The score of Patient Global Impression of Change (PGIC)
Time Frame: week 4
|
PGIC is a self-reported measure which reflects a patient's impression on the efficacy of treatment.
It is a 7-point scale detecting patient's rating on the overall improvement of treatment.
The patient can rate from 1 (very much improved) to 4 (no change) to 7 (very much worse).
|
week 4
|
The score of Patient Global Impression of Change (PGIC)
Time Frame: week 6
|
PGIC is a self-reported measure which reflects a patient's impression on the efficacy of treatment.
It is a 7-point scale detecting patient's rating on the overall improvement of treatment.
The patient can rate from 1 (very much improved) to 4 (no change) to 7 (very much worse).
|
week 6
|
The score of Patient Global Impression of Change (PGIC)
Time Frame: week 8
|
PGIC is a self-reported measure which reflects a patient's impression on the efficacy of treatment.
It is a 7-point scale detecting patient's rating on the overall improvement of treatment.
The patient can rate from 1 (very much improved) to 4 (no change) to 7 (very much worse).
|
week 8
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Zhixiu LIN, PhD, Hong Kong Institute of Integrative Medicine
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Sleep-related Leg Cramps study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep-related Leg Cramps
-
Chinese University of Hong KongCompletedSleep-related Leg CrampsHong Kong
-
University of Wisconsin, MadisonMayday FundTerminated
-
University of Geneva, SwitzerlandCompletedNocturnal Leg Cramps | Sleep Wake Transition DisordersSwitzerland
-
Ying LiAffiliated Hospital of North Sichuan Medical CollegeEnrolling by invitationNocturnal Leg CrampsChina
-
China Medical University HospitalUnknown
-
Uzi MilmanTerminatedQuality of Life | Nocturnal Leg CrampsIsrael
-
Naveh Pharma LTDCompletedNocturnal Leg CrampsUkraine
-
Yonsei UniversityCompleted
-
Kars State HospitalEnrolling by invitationMyofascial Pain Syndrome | Nocturnal Leg CrampsTurkey
-
Sport and Spine Rehab Clinical Research FoundationCompletedLeg Cramp, NocturnalUnited States
Clinical Trials on Shaoyao Gancao Decoction with Addition
-
Chinese University of Hong KongCompletedSleep-related Leg CrampsHong Kong
-
Show Chwan Memorial HospitalRecruiting
-
Tianjin Medical University Cancer Institute and...CompletedHead and Neck CancerChina
-
Vastra Gotaland RegionCompletedMental Disorder | Behavior and Behavior Mechanisms | Psychological Phenomena and Processes | Behavioral Disciplines and ActivitiesSweden
-
ResMedUniversity Hospital, EssenCompletedRespiratory Insufficiency | Sleep Disordered BreathingGermany
-
ShuGuang HospitalCompletedGastric Cancer (Diagnosis)
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedHIV | Drug Use DisordersUnited States
-
Pamukkale UniversityRecruitingStroke | Spastic HemiplegiaTurkey
-
Shenzhen People's HospitalNot yet recruitingEndometriosis | NK Cell Mediated ImmunityChina